New York State Common Retirement Fund Vertex Pharmaceuticals Inc Transaction History

New York State Common Retirement Fund

  • $68.1 Billion
  • Q1 2025

A detailed history of New York State Common Retirement Fund transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, New York State Common Retirement Fund holds 345,796 shares of VRTX stock, worth $151 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares
345,796
Previous 362,334 4.56%
Holding current value
$151 Million
Previous $146 Million 14.9%
% of portfolio
0.25%
Previous 0.2%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 01, 2025
SELL
$402.49 - $513.76 $6.66 Million - $8.5 Million
-16,538 Reduced 4.56%
345,796 $168 Million
Q4 2024

Jan 31, 2025
BUY
$396.64 - $516.74 $1.13 Million - $1.48 Million
2,855 Added 0.79%
362,334 $146 Million
Q3 2024

Oct 28, 2024
SELL
$460.0 - $505.78 $13.4 Million - $14.7 Million
-29,073 Reduced 7.48%
359,479 $167 Million
Q2 2024

Jul 31, 2024
SELL
$392.81 - $485.53 $1.3 Million - $1.6 Million
-3,304 Reduced 0.84%
388,552 $182 Million
Q1 2024

May 07, 2024
SELL
$407.69 - $446.08 $7 Million - $7.66 Million
-17,170 Reduced 4.2%
391,856 $164 Million
Q4 2023

Feb 01, 2024
SELL
$343.0 - $410.68 $11.2 Million - $13.4 Million
-32,708 Reduced 7.4%
409,026 $166 Million
Q3 2023

Nov 07, 2023
SELL
$338.18 - $362.46 $9.29 Million - $9.95 Million
-27,459 Reduced 5.85%
441,734 $154 Million
Q2 2023

Aug 07, 2023
BUY
$314.42 - $351.91 $2.32 Million - $2.6 Million
7,379 Added 1.6%
469,193 $165 Million
Q1 2023

May 02, 2023
SELL
$283.23 - $323.1 $3.09 Million - $3.52 Million
-10,904 Reduced 2.31%
461,814 $146 Million
Q4 2022

Jan 30, 2023
BUY
$285.76 - $321.48 $636,673 - $716,257
2,228 Added 0.47%
472,718 $137 Million
Q3 2022

Nov 08, 2022
SELL
$273.83 - $305.53 $5.54 Million - $6.18 Million
-20,242 Reduced 4.12%
470,490 $136 Million
Q2 2022

Aug 04, 2022
BUY
$234.96 - $292.55 $1.02 Million - $1.26 Million
4,322 Added 0.89%
490,732 $138 Million
Q1 2022

May 05, 2022
SELL
$221.42 - $260.97 $761,241 - $897,214
-3,438 Reduced 0.7%
486,410 $127 Million
Q4 2021

Feb 02, 2022
SELL
$177.01 - $223.45 $2.4 Million - $3.02 Million
-13,535 Reduced 2.69%
489,848 $108 Million
Q3 2021

Nov 02, 2021
BUY
$181.39 - $202.99 $1.13 Million - $1.27 Million
6,248 Added 1.26%
503,383 $91.3 Million
Q2 2021

Aug 02, 2021
BUY
$187.49 - $221.1 $1.05 Million - $1.24 Million
5,588 Added 1.14%
497,135 $100 Million
Q1 2021

May 11, 2021
SELL
$207.02 - $241.31 $4.15 Million - $4.84 Million
-20,053 Reduced 3.92%
491,547 $106 Million
Q4 2020

Feb 08, 2021
SELL
$207.01 - $276.09 $5.75 Million - $7.68 Million
-27,800 Reduced 5.15%
511,600 $121 Million
Q3 2020

Nov 05, 2020
SELL
$255.65 - $303.1 $6.68 Million - $7.92 Million
-26,130 Reduced 4.62%
539,400 $147 Million
Q2 2020

Aug 07, 2020
SELL
$225.48 - $295.8 $839,913 - $1.1 Million
-3,725 Reduced 0.65%
565,530 $164 Million
Q1 2020

May 06, 2020
SELL
$199.77 - $247.81 $223,742 - $277,547
-1,120 Reduced 0.2%
569,255 $135 Million
Q4 2019

Feb 05, 2020
SELL
$166.71 - $223.91 $1.87 Million - $2.51 Million
-11,200 Reduced 1.93%
570,375 $125 Million
Q3 2019

Nov 07, 2019
BUY
$166.23 - $187.09 $831,150 - $935,450
5,000 Added 0.87%
581,575 $98.5 Million
Q2 2019

Aug 09, 2019
SELL
$164.61 - $190.37 $13.7 Million - $15.8 Million
-83,005 Reduced 12.58%
576,575 $106 Million
Q1 2019

May 08, 2019
SELL
$163.73 - $194.7 $8.66 Million - $10.3 Million
-52,900 Reduced 7.42%
659,580 $121 Million
Q4 2018

Feb 08, 2019
SELL
$151.91 - $192.21 $6.82 Million - $8.63 Million
-44,900 Reduced 5.93%
712,480 $118 Million
Q3 2018

Nov 07, 2018
SELL
$167.73 - $192.74 $3.3 Million - $3.8 Million
-19,700 Reduced 2.54%
757,380 $146 Million
Q2 2018

Aug 10, 2018
SELL
$145.72 - $169.96 $3.05 Million - $3.55 Million
-20,900 Reduced 2.62%
777,080 $132 Million
Q1 2018

May 10, 2018
SELL
$151.6 - $177.13 $6.42 Million - $7.5 Million
-42,351 Reduced 5.04%
797,980 $130 Million
Q4 2017

Feb 13, 2018
BUY
$137.28 - $155.55 $2.44 Million - $2.77 Million
17,800 Added 2.16%
840,331 $126 Million
Q3 2017

Nov 06, 2017
BUY
$148.13 - $162.24 $4.07 Million - $4.46 Million
27,484 Added 3.46%
822,531 $125 Million
Q2 2017

Aug 11, 2017
BUY
N/A
795,047
795,047 $102 Million

Others Institutions Holding VRTX

# of Institutions
1,830
Shares Held
233M
Call Options Held
1.38M
Put Options Held
1.08M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $112B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email